The downregulated miR-145 in patients with HCC can directly target the 3′-untranslated region of YTHDF2 mRNA to inhibit the expression of YTHDF2, which may be a new target for the treatment of HCC [13]. Here, YTHDF2 is linked to hepatocellular carcinoma.